Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 2, 2009, Pages 716-726

  Dong, Xiaowu ^a   Liu, Tao ^a   Yan, Jingying ^a   Wu, Peng ^a   Chen, Jing ^a   Hu, Yongzhou ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

3D QSAR; CoMFA; Flavonoids; Vasorelaxant activities

Indexed keywords

6 HYDROXY 8 ALLYL 4' CHLOROFLAVONONE; FLAVONOID; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; MALE; MELTING POINT; NONHUMAN; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; RELIABILITY; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; FLAVONES; FLAVONOIDS; MODELS, MOLECULAR; PHENYLEPHRINE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; VASODILATION;

RATTUS;

EID: 58549104105     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.11.052     Document Type: Article

References (21)

1. Ren W., Qiao Z., Wang H., Zhu L., and Zhang L. Med. Res. Rev. 23 (2003) 519-534
2. Carlo G.D., Mascolo N., lzzo A.A., and Capasso F. Life Sci. 65 (1999) 337-353
3. Tripoli E., Guardia M.L., Giammanco S., Majo D.D., and Giammanco M. Food Chem. 104 (2007) 466-479
4. Yochum L., 1 Kushi L.H., Meyer K., and Folsom A.R. Am. J. Epidemiol. 149 (1999) 943-949
5. Jenkins D.J.A., Kendall C.W.C., D'Costa M.A., Jackson C.J.A., Vidgen E., Singer W., Silverman J.A., Koumbridis G., Honey J., Rao A.V., Fleshner N., and Klotz L. J. Urol. 169 (2003) 507-511
6. Harborne J.B., and Williams C.A. Phytochemistry 55 (2000) 481-504
7. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., Hakulinen T., and Aromaa A. Am. J. Clin. Nutr. 76 (2002) 560-568
8. Fusi F., Saponara S., Pessina F., Gorelli B., and Sgaragli G. Eur. J. Nutr. 42 (2003) 10-17
9. Xu Y.C., Leung S.W.S., Yeung D.K.Y., Hu L.H., Chen G.H., Che C.M., and Man R.Y.K. Phytochemistry (2007) 1179-1188
10. Duarte J., Perez-vizcaino F., Jimenez J., Tamargo J., and Zarzuelo A. Stud. Nat. Prod. Chem. 25 (2001) 565-605
11. Mishra S.K., Abbot S.E., Choudhury A., Cheng M., Khatab N., Maycock N.J.R., Zavery A., and Aaronson P.I. Cardiovasc. Res. 46 (2000) 539-546
12. Zhang Y.H., Park Y.S., Kim T.J., Fang L.H., Ahn H.Y., Hong J.T., Kim Y., Lee C.K., and Yun Y.P. Gen. Pharmacol. 35 (2002) 341-347
13. Ajar M., Gilani A.H., and Mustafa M.R. Life Sci. 74 (2003) 603-612
14. Chen Z., Hu Y., Wu H., and Jiang H. Bioorg. Med. Chem. Lett. 14 (2004) 3949-3952
15. Yang G.F., and Huang X.Q. Curr. Pharm. Des. 12 (2006) 4601-4611
16. Cramer R.D., Patterson D.E., and Bunce J.D. J. Am. Chem. Soc. 110 (1988) 5959-5967
17. Fatemi M.H., and Gharaghani S. Bioorg. Med. Chem. 15 (2007) 7746-7754
18. Dong X., Fan Y., Yu L., and Hu Y. Arch. Pharm. Chem. Life Sci. 340 (2007) 372-376
19. Qian L., Wang H., Qiu W., Huang H., Bruce I.C., and Xia Q. Vascul. Pharmacol. 45 (2006) 374-382
20. sybyl Molecular Modeling System, Versions 5 and 6, TRIPOS Assoc., St. Louis, MO, U.S.A.
21. Wold S., Albano C., Dunn W., Edlund U., Esbensen K., Geladi P., Hellberg S., Johansson E., Lindberg W., and Sjosstrom M. In: Kolwalski B. (Ed). Chemometrics Vol. 1 (1987), Reidel, Dordrecht 17